Sulfonylureas
Glucotrol (glipizide), Micronase, DiaBeta, Glynase (glyburide), Amaryl (glimepiride)
Action: Stimulates release of insulin from pancreatic islets; decreases glycogenolysis and gluconeogenesis; enhances cellular sensitivity to insulin
Nursing Intervention:
- Monitor patient for weight gain
- Check blood sugar frequently to monitor for hypoglycemia
- More effective early in the treatment of diabetes and some patients experience decreased effectiveness of medication after prolonged use
Meglitinides
Prandin (repaglinide), Starlix (nateglindine)
Action: Stimulates a rapid and short-lived release if insulin from pancreas
Nursing Intervention
- Monitor patient for weight gain
- Check blood sugar frequently to monitor for hypoglycemia
- Taken just before meals to mimic normal release of insulin
- DO NOT TAKEIF MEAL IS SKIPPED
Biguanide
Glucophage, Riomet, Fortamet (metformin)
Action: Decrease rate of hepatic glucose production; augments glucose uptake by tissues/muscles
Nursing Intervention:
- Diarrhea, lactic acidosis
- DISCONTINUE BEFORE AND HOLD MEDICATION FOR 48 HRS AFTER ADMINISTRATION OF IV CONTRAST MEDIA (KIDNEY DAMAGE)
- Can be used with other oral diabetic medications
- Does not typically promote weight gain
- Can be used in patients with "prediabetes" to help prevent diabetes
Thiazolidinediones (TZDs)
Actos (pioglitazone), Avandia (rosiglitazone)
Action: Increase glucose uptake in muscle; decrease endogenous glucose production
Nursing Interventions
- Risk for weight gain, edema
- Not recommended for patients with heart failure
- "Insulin sensitizers"
- Most effective for people with insulin resistance
- Will not cause hypoglycemia when used alone
- May improve lipids and blood pressure
- Increased risk for bone fracture and macular edema
- Increased risk for liver impairment
Alpha Glucosidase Inhibitors
Precose (acarbose) Glyset (miglitol)
Action: Delay absorption of glucose from GI tract
Nursing Interventions
- Gas, abdominal pain, diarrhea
- Also known as "starch blockers"
- Take with first bite of meal
- Effective in lower post prandial glucose levels
- Not effective against fasting hyperglycemia
Incretin Mimetics
Exenatide & Liraglutide
Developed from the saliva of the Gila monster
Stimulates insulin resistance
Decrease glucagon secretion
Increased satiety
Decreased gastric emptying
Increased risk for pancreatitis
Increased risk for thyroid cancer
Dipeptidyl Peptidase-4 (DDP-4) Inhibitors
Januvia (sitagliptin),
Action: Enhances the incretin system, stimulates release of insulin from pancreatic B cells and decreases hepatic glucose production
Nursing Intervention:
- Increased risk for acute pancreatitis
- Drug is glucose dependent
- Lower potential for hypoglycemia
Amylin Analog
Pramlintide: amylin is a hormone that is released into the bloodstream by the beta cells of the pancreas along with insulin, after a meal. Like insulin, amylin is deficient in individuals with Type 1 diabetes. It slows down the movement of food through the stomach. Researchers developed the drug from rat amylin
Pramlintide is approved for use in type 1 diabetes
Decreased gastric emptying
Decreased glucagon secretion
Decreased hepatic glucose output
Increased satieity
Side effects:
- Severe hypoglycemia
- Nausea and Vomitting
Sodium-Glucose Co-Transport Inhibitors
Lower blood glucose levels by preventing kidney reabsorption of the glucose that was filtered from the blood into the urine. Glucose is excreted in the urine rather than moved back into the blood.
Drugs: Canagliflozin (Invokana) and dapagliflozin (Farxiga)
Hypoglycemia (hunger, headache, tremors, sweating, confusion) can occur because these drugs lower blood glucose levels even when they are not elevated
Dehydration (increased thirst, lightheadedness, dry mouth, and mucous membranes, orthostatic hypotension) can occur because these drugs increase urine output and increase dehydration risk
Hyponatremia (muscle weakness, decreased ability to concentrate, abdominal cramping, rapid heart rate, orthostatic hypotension) can occur because these drugs increase sodium excretion
Urinary Tract Infection (frequency, pain and burning on urination, foul urine odor) can occur because the increased glucose in the urinary tract predisposes to infection
GENITAL ITCHING AND VAGINAL DISCHARGE CAN OOCUR BECAUSE THESE DRUGS INCREASE THE RISK FOR GENITAL YEAST INFECTION
Rapid Acting
Lispro (Humalog), Aspart (Novolog), Glulisine (Apidra)
Starts to work in: 15-30 minutes
Peak Action: 1-2 hours
Duration of Action: 3-6 hours
Maximum Duration: 4-6 hours
Short Acting
Regular
Starts to work in: 30 min - 1 hour
Peak Action: 2-4 Hours
Duration of Action: 3-6 hours
Maximum Duration: 6-8 hours
Intermediate-Acting
NPH
Starts to work in: 2-4 hours
Peak Action: 8-10 hours
Duration of Action: 10-18 hours
Maximum Duration: 14-20 hours
Long Acting
Glargine (Lantus) and Detemir (Levemir)
Starts to work in: 1-2 hours
Peak Action: NONE
Duration of Action: 19-24 & 19-20 hours
Maximum Duration: 24 & 20 hours